Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
Date:11/5/2013

e months ending December 31, 2013. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Cadence's actual future results may differ materially from Cadence's current expectations due to the risks and uncertainties inherent in its business. These risks include, but are not limited to: Cadence's dependence on the successful commercialization of OFIRMEV, which is the company's only product; Cadence's ability to achieve broad market acceptance and generate revenues from sales of OFIRMEV; Cadence's dependence on its contract manufacturers and its ability to ensure an adequate and continued supply of OFIRMEV to meet market demand; Cadence's ability to successfully enforce its marketing exclusivities and intellectual property rights, and to defend the patents covering OFIRMEV, including in current intellectual property litigation with the parties that have submitted new drug applications ("NDAs") or abbreviated new drug applications ("ANDAs") for generic versions of OFIRMEV; the potential that Cadence may be required to continue intellectual property litigation for substantial lengths of time or file additional lawsuits to defend its patent rights from challenges by companies that have submitted NDAs or ANDAs for generic versions of OFIRMEV, and the substantial costs associated with such lawsuits; the potential introduction of generic competition to OFIRMEV in the event Cadence is unsuccessful in current or future intellectual property litigation, and the impact it may have on the sales and pricing of the product; Cadence's dependence on its licensors for the maintenance and enforcement of its intellectual property rights; the potential product liability exposure associated with pharmaceutical products such as OFIRMEV and other products Cadence may in-license or acquire; Cadence's ability to fully comply with numerous federal, state and local laws and regulatory requirements that apply to its commercial a
'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
2. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
3. Cadence Pharmaceuticals Comments on USPTOs Non-Final, Initial Office Action on Reexamination of Patent
4. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
5. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
6. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
7. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
8. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
10. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
11. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Switzerland , October 1, 2014 ... in Clinical Genomics and Next Generation Sequencing (NGS) data ... clinicians to run full cystic fibrosis analysis in a ... identification and characterisation of all types of variants in ... Until now, it has not been possible ...
(Date:9/30/2014)... 30, 2014 This report analyzes the worldwide markets ... Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. ... Canada, Japan , Europe ... , and Rest of World. Annual estimates and forecasts ... six-year historic analysis is provided for these markets. ...
(Date:9/30/2014)... Mass. , Sept. 30, 2014  Hologic, Inc. ... Stephen MacMillan , Hologic,s President and Chief Executive Officer, ... Ceremony on October 1, the first day of Breast ... discuss the Company,s campaign focused on the important benefits ... approved by the FDA as clinically superior to traditional ...
Breaking Medicine Technology:Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
(Date:10/1/2014)... 2014 Phoseon Technology, the pioneer in ... expand the business worldwide. This rapid growth includes increased ... for manufacturing efforts. The company has experienced average annual ... and expects this growth to continue in the future ... worldwide adoption. , “We are very pleased that ...
(Date:10/1/2014)... from Duke Medicine suggests that some people who are ... hard-wired to gain weight when exposed to chronic stress, ... 13 percent of people, all of whom are Caucasian, ... help them reduce heart disease with simple interventions such ... "Genetic susceptibility, psychosocial stress and metabolic factors act in ...
(Date:10/1/2014)... Diet Doc understands that many of their clients have ... dieting attempts could be easily sabotaged by the temptation to ... into their programs as a way to control the ... weight loss results, it also allows patients to stick with ... weight for the future. , Earlier versions of the hormone ...
(Date:10/1/2014)... 2014 On Sept. 9, Chapín Coffee ... the Martha Stewart American Made Awards (MSAMAs), an annual ... country in the fields of crafts, design, food and ... a finalist in the MSAMAs, which celebrates entrepreneurs and ... improving local communities and changing the way we shop, ...
(Date:10/1/2014)... WOODLAND HILLS, CA (PRWEB) October 01, 2014 ... Mamaly Reshad will speak to a group of dental ... week in the northern Spain city of Oviedo. Dr. ... known prosthodontist and lecturer with clients on two continents, ... mouth complex and aesthetic full mouth reconstruction. , “These ...
Breaking Medicine News(10 mins):Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4
... Joel T. Allison, FACHE, president/CEO of Baylor Health Care ... of the Texas Hospital Association,s Earl M. Collier Award ... Collier Award is the highest honor bestowed by THA. ... annual Leadership Conference in Austin."Joel Allison exemplifies the leadership ...
... 22 ATS Medical, Inc.,(Nasdaq: ATSI ... and services, today announced its participation in the ... (STS) and related,company-sponsored events. The meeting runs ... as one of the year,s key gatherings of,cardiovascular ...
... School of Medicine have discovered how a whole class ... Their findings, reported online this week at the ... Edition, suggest that a subgroup of cancer patients might ... of chemotherapeutics doxorubicin (Adriamycin), daunorubicin, epirubicin, idarubicin ...
... N.C., Jan. 22 Nearly 2,500 dentists, dental,hygienists, dental ... take part in the sixth annual national "Give Kids ... to be among the largest events of its kind,in ... other dental professionals will volunteer their time at,designated dental ...
... Recovery Group, Inc. (IRG) announce the formation of Impairment Resources, ... assure accurate and reliable impairment ratings. Impairment Resources will combine ... of the AMA Guides to the Evaluation of Permanent Impairment, ... ...
... fuel rise in employee engagementMINNEAPOLIS, Jan. 22 ... productivity solutions grew in 2008, due to ... incentives. HealthFitness (NYSE Alternext US: FIT) is ... and fitness management solutions for on-site and ...
Cached Medicine News:Health News:Allison Honored with Hospital Association's Highest Award 2Health News:Allison Honored with Hospital Association's Highest Award 3Health News:ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting 2Health News:ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting 3Health News:ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting 4Health News:How chemotherapy drugs block blood vessel growth, slow cancer spread 2Health News:How chemotherapy drugs block blood vessel growth, slow cancer spread 3Health News:North Carolina Dentists Team Up To Treat Needy Children 2Health News:Brigham and Associates and Insurance Recovery Group Launch Impairment Resources, a Joint Venture to Address Impairment Ratings 2Health News:Brigham and Associates and Insurance Recovery Group Launch Impairment Resources, a Joint Venture to Address Impairment Ratings 3Health News:Biometric Screening, Health Coaching and HRA Participation Grows in 2008 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: